The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/jad-170101
PubMed Identifier: 29226862
Publication URI: http://europepmc.org/abstract/MED/29226862
Type: Journal Article/Review
Volume: 61
Parent Publication: Journal of Alzheimer's disease : JAD
Issue: 2
ISSN: 1387-2877